Serbian Viagra at the German market

On the same day when the patent for active substance for Viagra expired, STADA started selling the first generic sildenafil, the drug for erectile dysfunction, produced in Hemofarm plant in Vršac.

The same drug has been developed and launched in Serbia under the brand name Sildena, its price making it more affordable than other drugs from the same group. In Germany, Sildenafil will be ten times cheaper than Viagra.

The regulations in Germany do not allow the products protected by patent to be stored and sold. Since Hemofarm is a member of STADA Group since 2006, STADA had the opportunity to produce the first generic drug for erectile dysfunction in Serbia and to launch Sildenafil to German market immediately after the patent protection expiration.

‘We enriched our portfolio with a quality product for the treatment of erectile dysfunction. Sildena is a bioequivalent of Viagra, but more affordable. It is very important for men with that problem. Launching Sildena will enable men with that problem to have more qualitative life’, Hartmut Retzlaff, CEO of STADA Group stated.

Sildenafil was launched on 24th June in Germany and Western Europe (Austria, Switzerland, Netherlands, Belgium, Denmark, Sweden, Italy, Ireland, Spain, Romania) in the form of coated tablets of 25, 50 and 100 mg. 100 mg tablets have the shape that enables them to be divided into four parts, depending on the use.

‘Our product can be adapted to individual patients’ needs, which is, beside the price, one of the advantages for users. The package is of very discreet design. Therefore, users can take it anywhere without being uncomfortable’, Hartmut Retzlaff pointed out.

In accordance with the domestic Law on medicine products and medical devices, Hemofarm submitted a request for the registration of sildenafil in 2009. Hemofarm is the first company in Serbia which has a license to produce and sell generic sildenafil.